Hi, I will root for you no matter whether I invest, and congratulations on your success so far. Can you elaborate on your IP. I'm a little confused because you are patenting tech you are licensing. Who will hold the patent and what will the terms be? How can you be reasonably ...

Hi there! Great questions. Will break down below: "Can you elaborate on your IP. I'm a little confused because you are patenting tech you are licensing. Who will hold the patent and what will the terms be? How can you be reasonably sure you'll get the patent, and if you do, is there a way for companies to do something fairly similar, not violate the patent, and get to the same result (how broad is it)?"Answer: This is an important question as IP is the lifeblood of biotech companies, and...

Given the teams pedigree and YC affiliation, why are you raising capital via crowd? Are you raising additional funds via traditional methods? Is this business not a fit for mainstream VCs for some reason?

Hi Howard,Great questions.We are definitely still in discussions with VCs outside of Wefunder and have multiple funds and angels who are interested but are "waiting for a lead". We also thought this was a great way to include our many friends/family who wanted to support us but without crowdfunding wouldn't be able to. And, most importantly, we thought this would be a terrific medium to get the world of passionate dog owners behind our backs, on our cap table, and empowered with the...

@Wesley you should add Jorge Conde at a16z to your list of vc's to talk to. I think he understands and is interested in the the dog <-> human connection and how they benefit each other. Article about one health- a dog health care company they invested in: https://a16z.co...

Thanks for the recommendation. We spoke with Jeffrey Low there previously but their team wished to see more data from our end before investing. After we treat a few dogs with the money we raise on Wefunder they are on the short list of groups to reach out to for a Series A!

Are you doing any type of research on Hemangiosarcoma in dogs?

Hi Gregg,Currently we are not, and hemangiosarcoma is not on our short list for cancers that we could easily target with CAR T cell therapy. We would love to some day work towards tackling this problem. Our friends at One Health Company are indeed working on hemangiosarcoma, and if this question comes because you have a pressing issue with a canine family member I recommend reaching out to them!Best of luck, Wes

What about oral melanoma? It is very progressive cancer.

Hi Ozlen,There is a melanoma vaccine on the market today called Oncept. Melanoma is a tough target for CAR T cells, but we'd love to have the ability to work on solutions to this cancer type in the future. Currently, we're staying focused on B cell lymphoma.Cheers,Wes

LEAH Labs

Human's best science for human's best friend 👨🏻‍🔬 🧬 🐶

leahlabs.com

Rochester, MN

Technology Y Combinator B2B Healthcare Science & R&D

Investor Panel

Luke interviewed LEAH Labs on March 30, 2021. Play Video

Luke Iseman

Founder of boxouse, growerbot, Soil IQ, Dirtnail, and more. Former Director of Hardware at Y Combinator.

Strengths

says, "Wesley and team have a compelling plan to fight cancer in companion animals."

Advice

says, "Fleshing out more detail between now and 2024's therapy sales live could be compelling."

What Investors Say

What Friends Say

What People Say

LEAH Labs

Quick facts

Team profiles

$866,493

Investor Panel

What Investors Say

What Friends Say